Description:

• Synergistic Antimalarial Combination (ACT): Combines Artemether, a fast-acting artemisinin derivative that rapidly reduces the parasite burden, with Lumefantrine, a longer-acting antimalarial that clears remaining parasites to prevent recrudescence.

• Gold-Standard Treatment for Falciparum Malaria: Specifically indicated for the oral treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including multi-drug resistant strains.

• Double-Strength (DS) Formulation: Features a high-potency 40/240mg ratio, reducing the pill burden for adults and children over 35kg compared to standard-strength combinations.

• 8-Tablet Targeted Treatment Pack: Supplied in a targeted pack of 8 tablets, aligning perfectly with standard multi-dose therapeutic guidelines to ensure full clinical cure.